Literature DB >> 28888426

Sudden sensorineural hearing loss in children and adolescents: Clinical characteristics and age-related prognosis.

Jin Youp Kim1, Jae Joon Han1, Woong Sang Sunwoo1, Ja-Won Koo2, Seung-Ha Oh3, Min-Hyun Park1, Young Ho Kim4.   

Abstract

OBJECTIVE: Although many studies have investigated sudden sensorineural hearing loss (SSNHL) in adults, there were few studies on SSNHL in the pediatric population; especially research on treatment and prognosis of pediatric SSNHL was limited. The aim of this study was to evaluate clinical characteristics, treatment outcomes and prognostic factors in children and adolescents with SSNHL.
METHODS: A retrospective review of medical records of 67 pediatric patients (67 ears) who had diagnosed with SSNHL at our hospitals was performed to analyze patients' clinical manifestations and audiograms. All patients were treated with high-dose systemic prednisolone (1mg/kg), and 17 of them underwent intratympanic steroid injection therapy. Audiological evaluation was carried out before and after treatment, and hearing recovery was defined as complete recovery and partial recovery according to Siegel's criteria. Patients were divided into two groups: childhood group (ages between 4 and 12 years old) and adolescence group (age>12years), and clinical characteristics and treatment outcomes were investigated. In addition, patients were divided into two groups according to degree of hearing recovery, and evaluation was made regarding possible prognostic factors.
RESULTS: The recovery rate in total 67 patients was 55.2%. The recovery rate of the childhood group was significantly lower than that of the adolescence group (p=0.038). While the presence of vertigo did not significantly correlate with prognosis (p=0.219), the presence of tinnitus was significantly associated with hearing recovery (p=0.005). Audiological assessment revealed that a low initial hearing threshold, high speech discrimination score, and descending type of audiogram were positively associated with hearing recovery (p=0.002, p=0.003, and p=0.029, respectively).
CONCLUSION: The childhood group had worse treatment outcomes than the adolescence group. High initial hearing threshold and absence of tinnitus were poor prognostic factors of hearing recovery. Active treatment is required for patients with these poor prognostic factors and childhood patients with SSNHL.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age; Children; Pediatric; Prognosis; Sudden sensorineural hearing loss

Mesh:

Substances:

Year:  2017        PMID: 28888426     DOI: 10.1016/j.anl.2017.08.010

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  5 in total

1.  Paediatric Sudden Sensorineural Hearing Loss: Pooled Analysis and Systematic Review.

Authors:  Jacob C S Reading; Andrew Hall; Robert Nash
Journal:  J Int Adv Otol       Date:  2021-01       Impact factor: 1.017

2.  The Outcome of Prompt Concomitant Single-Dose High-Concentration Intratympanic and Tapered Low-Dose Oral Systemic Corticosteroid Treatment for Sudden Deafness.

Authors:  Špela Kordiš; Domen Vozel; Manja Hribar; Nina Božanić Urbančič; Saba Battelino
Journal:  J Int Adv Otol       Date:  2020-08       Impact factor: 1.017

3.  Sudden Sensorineural Hearing Loss in Children: Clinical Characteristics, Etiology, Treatment Outcomes, and Prognostic Factors.

Authors:  Yuqing Lu; Liangqiang Zhou; Tejvansh Shenoy Imrit; Aiguo Liu
Journal:  Otol Neurotol       Date:  2019-04       Impact factor: 2.311

4.  Long-term administration of vitamin B12 and adenosine triphosphate for idiopathic sudden sensorineural hearing loss: a retrospective study.

Authors:  Takaomi Kurioka; Hajime Sano; Shogo Furuki; Taku Yamashita
Journal:  PeerJ       Date:  2020-12-16       Impact factor: 2.984

5.  A Hospital based study on sudden sensorineural Hearing Loss: It's audiological characteristics and prevalence.

Authors:  Erum Naz; Ghulam Saqulain; Nazia Mumtaz; Muhammad Naveed Babur
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.